EUVIMEDEUVIMED entdecken
Crossref

Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents

Xiaoyan Zheng, Dongying Zhao, Liwei Wang, Yiwen Wang, Yan Chen iD, Yongjun Zhang iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Xiaoyan Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China. Hauptthemen laut MEDLINE: Cardiometabolic Risk Factors, Fatty Liver, Metabolic Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Metabolic dysfunction-associated steatotic liver disease (MASLD) is widespread worldwide, and a strong link between MASLD and cardiometabolic risk factors (CMRFs) was highlighted in this study.

Objective

This study characterized the prevalence of MASLD in adolescent population and overlapping CMRFs conditions in MASLD.

Methods

This is a cross-sectional study of US adolescents aged 12 to 19 years in the 2017 through 2020 cycles of the National Health and Nutrition Examination Survey. The relationship between CMRFs and liver steatosis, evaluated by the median controlled attenuation parameter (CAP), was assessed.

Results

The prevalence of MASLD in adolescents was 23.77%. Isolated overweight/obesity (35%) was the top CMRF. Non-Hispanic Black patients had the highest proportion of overweight/obesity plus elevated glucose (24%), whereas non-Hispanic Asians had the highest burden of dyslipidemia (2%, 14%, and 19%). Except for hypertension, overweight/obesity (β = 48.7; 95% CI, 43.4-54.0), hypertriglyceridemia (β = 15.5; 95% CI, 7.2-28.3), low HDL-C (β = 10.0; 95% CI, 3.1-16.9), elevated glucose (β = 6.9; 95% CI, 0.6-13.2) were all significantly associated with increased CAP values. Increased CAP was linked to the synergistic interactions between overweight/obesity and dyslipidemia or elevated glucose (overweight/obesity and elevated glucose: relative excess risk due to interaction [RERI] = 8.21, attributable proportion due to interaction [AP] = 0.45, synergy index [SI] = 1.91; overweight/obesity and hypertriglyceridemia: RERI = 19.00, AP = 0.69, SI = 3.53; overweight/obesity and low high-density lipoprotein cholesterol: RERI = 10.83, AP = 0.58, SI = 2.61). Adolescents with combination of overweight/obesity, dyslipidemia (β = 15.1; 95% CI, 0.1-30.2) and combination of overweight/obesity, dyslipidemia and elevated glucose (β = 48.0; 95% CI, 23.3-72.6) had a significantly higher CAP values.

Conclusion

The prevalence of MASLD was alarmingly high in adolescents, and overweight/obesity was the most important CMRF. Overweight/obesity and dyslipidemia or elevated glucose had positive additive interaction effects on liver steatosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiometabolic Risk FactorsFatty LiverMetabolic SyndromeHumansAdolescentMaleFemaleCross-Sectional StudiesPrevalenceChildUnited StatesYoung AdultNutrition SurveysDyslipidemiasRisk FactorsPediatric ObesityPrognosis

Stichwörter der Autor:innen

adolescentcardiometabolic risk factorsmetabolic dysfunction-associated steatotic liver diseaseprevalence

Autor:innen und Institutionen

  • Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
  • Department of Nursing, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
  • Shanghai Institute for Pediatric Research, Shanghai Jiao Tong University School of Medicine, Xinhua Hospital, Shanghai 200092, China.

ORCID-Profile: Yan Chen, Yongjun Zhang

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Zheng, X., Zhao, D., Wang, L., Wang, Y., Chen, Y., & Zhang, Y. (2025). Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae553

Vancouver

Zheng X, Zhao D, Wang L, Wang Y, Chen Y, Zhang Y. Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae553

BibTeX
@article{Zheng2025,
  author = {Zheng, Xiaoyan and Zhao, Dongying and Wang, Liwei and Wang, Yiwen and Chen, Yan and Zhang, Yongjun},
  title = {Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae553}
}
Kostenlos starten →